MyAverix Finance
F · Healthcare
Addex Therapeutics Ltd (APE1)
Biotechnology
Addex Therapeutics Ltd (APE1) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for APE1
Addex Therapeutics Ltd (APE1) — FAQ
What is APE1's P/E ratio?
The price-to-earnings (P/E) ratio for Addex Therapeutics Ltd (APE1) is 18.00 (data as of 2026-03-25).
Does Addex Therapeutics Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Addex Therapeutics Ltd (APE1). Check the MyAverix Finance app for the latest dividend data.
What sector is Addex Therapeutics Ltd in?
Addex Therapeutics Ltd (APE1) is classified in the Healthcare sector (Biotechnology industry).
What exchange is APE1 listed on?
APE1 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.